Beryl Drugs Limited (BOM:524606)
India · Delayed Price · Currency is INR 20.00
-1.00 (-4.76%)
At close: May 7, 2026
Beryl Drugs Market Cap
Beryl Drugs has a market cap or net worth of 106.51 million as of May 7, 2026. Its market cap has decreased by -5.19% in one year.
Market Cap
106.51M
Enterprise Value
148.85M
Revenue
176.65M
Ranking
n/a
PE Ratio
755.36
Stock Price
20.00
Market Cap Chart
Since June 14, 2005, Beryl Drugs's market cap has increased from 3.69M to 106.51M, an increase of 2,782.96%. That is a compound annual growth rate of 17.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 106.51M | -10.26% |
| Dec 31, 2025 | 118.68M | -35.27% |
| Dec 31, 2024 | 183.34M | 63.50% |
| Dec 29, 2023 | 112.14M | 70.08% |
| Dec 30, 2022 | 65.93M | 7.26% |
| Dec 31, 2021 | 61.47M | 54.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Desh Rakshak Aushdhalaya | 141.32M |
| Norris Medicines | 140.01M |
| Emmessar Biotech & Nutrition | 126.40M |
| Parmax Pharma | 121.55M |
| Colinz Laboratories | 120.24M |
| Shamrock Industrial Company | 115.99M |
| Ortin Global | 114.00M |
| Unjha Formulations | 96.24M |